Tandem Mobi Pump and the Dexcom G7 CGM Are Now Connected

On May 29, 2024, Tandem Diabetes Care and Dexcom, Inc. shared exciting news: the Tandem Mobi insulin pump is now fully compatible with the Dexcom G7 continuous glucose monitor (CGM).

This tech combo is a game-changer for people with diabetes! The Tandem Mobi works with both the Dexcom G7 and G6 to predict blood sugar 30 minutes ahead. It even adjusts insulin automatically to help prevent spikes and lows.

With the new integration, Tandem Mobi users can enjoy:

• More time in closed loop, thanks to Dexcom G7’s quick 30-minute sensor warm-up.
• A sleeker experience with the Dexcom G7’s low-profile, all-in-one design.

This collaboration aims to make diabetes management easier and more seamless than ever.

Advanced Control-IQ technology

Control-IQ, the pump’s advanced hybrid closed-loop system, predicts blood sugar levels and adjusts insulin to avoid highs and lows. This tool improves time in range , keeping users healthier day and night.

FDA approval and launch highlights

Approved by the FDA in July 2023 for ages six and up, Tandem Mobi debuted in the U.S. as the smallest and most durable automated insulin delivery (AID) system.

Flexibility and innovation for diabetes management

“With this integration, we’re giving users more flexibility and extending our long-standing partnership with Dexcom to offer discreet, innovative solutions,” said John Sheridan, president and CEO of Tandem Diabetes Care.

Better glucose control for easier diabetes care

This collaboration promises improved glucose control while making diabetes management smoother than ever.